- Bedoelde u
- commercialisation
Zoekresultaten - 4 results
Calibration of Ph. Eur. BRP batch 4 for oral poliomyelitis vaccine (OPV)
the collaborative study to calibrate the candidate BRP (cBRP), a commercial trivalent OPV containing live attenuated poliovirus types 1, 2 and 3 (Sabin strain), against the WHO 2nd International ...
Validation of a new ELISA method for in vitro potency testing of hepatitis A vaccines
hepatitis A virus antigen content in hepatitis A vaccines(HAV) marketed in Europe. This became necessary due to issues with the method used previously, requiring the use of commercial test kits. The selected ...
Comparative study of five commercial kits for DNA extraction from urine samples.
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: L. El Bali; Nancy Roosens; Sigrid C.J. De Keersmaecker Source: WIV-ISP, Brussels, p.15 (2012) ISBN: D/2012/2505/69 Keywords: Comparative Study Dna DNA extraction kit ...
Guidelines for molecular characterisation of genetically modified higher plants for a standard part B consent according to Annex III B of Directive 2001/18/EC
commercial release of a genetically modified (GM) plant, require information for risk assessment, including molecular data. In carrying out its assessments, the SBB has noted a variation among dossiers in both ...